RO85901B - Procedeu de obtinere a unei glicoproteine cu actiune antitumorala - Google Patents

Procedeu de obtinere a unei glicoproteine cu actiune antitumorala

Info

Publication number
RO85901B
RO85901B RO110170A RO11017083A RO85901B RO 85901 B RO85901 B RO 85901B RO 110170 A RO110170 A RO 110170A RO 11017083 A RO11017083 A RO 11017083A RO 85901 B RO85901 B RO 85901B
Authority
RO
Romania
Prior art keywords
cells
human
glycoprotein
preparing
blooded animals
Prior art date
Application number
RO110170A
Other languages
English (en)
Other versions
RO85901A (ro
Inventor
Haruo Ohnishi
Kazuo Yamaguchi
Yasuo Suzuki
Ei Mochida
Nobuo Mochida
Original Assignee
Mochida Pharmaceutical Co Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharmaceutical Co Ltd. filed Critical Mochida Pharmaceutical Co Ltd.
Publication of RO85901A publication Critical patent/RO85901A/ro
Publication of RO85901B publication Critical patent/RO85901B/ro

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/828Cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Inventia se refera la un procedeu de obtinere a unei glicoproteine cu actiune antitumorala, procedeu ce consta în faptul ca se cultiva celulele nestabilizate alese dintre macrofagi si limfocite de origine umana sau neumana de la animale cu sînge cald dau celule din linii de celule stabilizate provenind de la celulele umane sau celulele de la animale cu sînge cald, într-un mediu Eagle ce contine 5...10% ser uman sau ser de vitel, la temperatura de 37 degree C, timp de 48 ore, într-o atmosfera constînd din 5% bioxid de carbon si 95% aer, dupa care glicoproteina obtinuta se izoleaza dupa metode cunoscute în sine.
RO110170A 1982-02-26 1983-02-26 Procedeu de obtinere a unei glicoproteine cu actiune antitumorala RO85901B (ro)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤

Publications (2)

Publication Number Publication Date
RO85901A RO85901A (ro) 1985-01-24
RO85901B true RO85901B (ro) 1985-01-30

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
RO110170A RO85901B (ro) 1982-02-26 1983-02-26 Procedeu de obtinere a unei glicoproteine cu actiune antitumorala

Country Status (17)

Country Link
US (1) US4481137A (ro)
BE (1) BE896027A (ro)
BR (1) BR8300933A (ro)
DD (1) DD209634A5 (ro)
DE (1) DE3306297A1 (ro)
DK (1) DK93383A (ro)
FI (1) FI830638L (ro)
FR (1) FR2522267A1 (ro)
GB (1) GB2117385B (ro)
GR (1) GR78097B (ro)
LU (1) LU84662A1 (ro)
NL (1) NL8300727A (ro)
NO (1) NO830669L (ro)
PL (1) PL240784A1 (ro)
PT (1) PT76296B (ro)
RO (1) RO85901B (ro)
SE (1) SE8301073L (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインiiiとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
WO1990000400A1 (en) * 1988-07-15 1990-01-25 The Trustees Of Columbia University In The City Of New York Tumor necrosis enhancing factor and methods of preparation and use
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度tcf製剤
US5641867A (en) 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び/又は治療剤
CA2253629A1 (en) 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent for preventing and/or treating cachexia
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
AU2004273783A1 (en) 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
ES2551922T3 (es) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Sistemas rápidos de purificación celular
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
EP3278115A2 (en) 2015-03-30 2018-02-07 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
US4481137A (en) 1984-11-06
NL8300727A (nl) 1983-09-16
GB2117385B (en) 1985-05-09
PT76296A (en) 1983-03-01
LU84662A1 (fr) 1983-09-08
BR8300933A (pt) 1983-11-16
GB8305330D0 (en) 1983-03-30
DE3306297A1 (de) 1983-09-15
PT76296B (en) 1985-11-12
NO830669L (no) 1983-08-29
GB2117385A (en) 1983-10-12
DK93383D0 (da) 1983-02-25
DD209634A5 (de) 1984-05-16
SE8301073L (sv) 1983-08-27
SE8301073D0 (sv) 1983-02-25
FR2522267A1 (fr) 1983-09-02
PL240784A1 (en) 1983-11-07
FI830638L (fi) 1983-08-27
DK93383A (da) 1983-08-27
FI830638A0 (fi) 1983-02-25
GR78097B (ro) 1984-09-26
RO85901A (ro) 1985-01-24
BE896027A (fr) 1983-08-25

Similar Documents

Publication Publication Date Title
RO85901B (ro) Procedeu de obtinere a unei glicoproteine cu actiune antitumorala
Comparini et al. Electrophoretic evidence for two species of Anguilla leptocephali in the Sargasso Sea
IT1209941B (it) Procedimento di trattamento di cellule con proteine ossee solubili per renderle idonee a stimolare la crescita di tessuti cartilaginei ed ossei,e prodotto ottenuto
MY101972A (en) Primate interleukin - 4
GB2196636B (en) Production of proteins by cell culture
KR890700672A (ko) 혈소판과 관계된 생장조절제
Soltis Allozymic differentiation among Heuchera americana, H. parviflora, H. pubescens, and H. villosa (Saxifragaceae)
El-Kassaby Genetic interpretation of malate dehydrogenase isozymes in some conifer species
Mayr et al. Human chimaera detectable only by investigation of her progeny
Singh et al. Investigation of some biochemical genetic markers in four endogamous groups from Panjab (NW India) I. Protein and enzyme polymorphisms in serum
Paster et al. Gibberellic acid: a growth factor in the unicellular alga Gymnodinium breve
Khan et al. Assignment of the mitochondrial aconitase gene (ACONM) to human chromosome 22
Baker et al. Erophylla sezekorni
SE8605459D0 (sv) Novel cell growth regulatory factor
IT1184884B (it) Procedimento per la coltura di cellule mediante dispersione di gas
ES8801582A1 (es) Un procedimiento para preparar una composicion farmaceutica de una linfocina (lk2).
EP0462792A3 (en) Process for obtaining cellular protein having anti-hiv activity
Weinstein et al. Assay of Cytochrome Oxidase Activity of Sunflower Leaf Tissue in Relation to pH Value and Cation Concentration of the Buffer.
Auel et al. The mitotic Ca2+-adenosine triphosphatase in proliferating tissue of Vicia faba
Pacho Genetic and environmental sources of variations in Angus and Brahman cattle.
Gabina et al. Improvement of reproductive performance in Rasa Aragonesa. Present results in selection and crossbreeding experiment
RO86418B1 (ro) Procedeu de preparare a antigenului de pneumocistis carinii
Drescher et al. Analysis of the Giemsa‐banding patterns of the chromosomes from rats carrying the genes of the growth and reproduction complex (grc)
YU43881B (en) Process for obtaining crystalline salt of s-6-fluor-4-(benzyloxi-carbonylamino )chroman-4-carbonic acid
Pronk A genetic variant of amylase from human parotid saliva detected by isoelectric focusing